Other languages Filament Health Corp.

Equities

FLHLF

CA31685W1068

Delayed OTC Markets Other stock markets 09:52:09 2024-04-26 am EDT			5-day change	1st Jan Change
0.0344 ^USD	-1.29%		-8.75%	-36.41%

Apr. 03	Filament Health Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 28	Filament Health Corp. Announces Appointment of Michael Messinger to Its Board of Directors and Chair of the Audit Committee	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Filament Health Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 02
Filament Health Corp. Announces Appointment of Michael Messinger to Its Board of Directors and Chair of the Audit Committee	Mar. 28
Filament Health Corp. Announces Shipments of Botanical Psilocybin to Four Countries for Clinical Investigation	Mar. 19
Filament Health Corp. Completes the First Export of Botanical Psilocybin to Israel	Feb. 15
Filament Health Announces FDA Opening of Investigational New Drug Application for Substance Use Disorders	Jan. 31
Filament Health Completes the First Export of Biological Psilocybin to Australia	Jan. 17
Filament Health Announces Change to Board of Directors	Jan. 02
Filament Health Corp. (OTCPK:FLHL.F) cancelled the acquisition of Jupiter Acquisition Corporation from a group of shareholders in a reverse merger transaction.	Dec. 17
Filament Health Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13
Filament Health Announces Health Canada Authorization for Phase 2 Clinical Trial Studying Botanical Psilocybin for Opioid Use Disorder	23-10-09
Filament Health Corp. Enters Licensing Agreement with Reset Pharmaceuticals Inc	23-08-30
Filament Health Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-13
Filament Health Corp. Announces FDA Approval of Two Clinical Trials Studying Its Biological Psychedelic Drug Candidate PEX010	23-08-08
Filament Health Corp. to Supply Psilocybin for Two Clinical Trials	23-07-07
Filament Health Corp. Enters Exclusive Licensing Agreement with NeoLumina Bioscience Inc	23-06-30
Filament Health Corp. Announces Interim Results from Phase I Clinical Trial at the University of California, San Francisco	23-05-30
Filament Health Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12
Pharmala Biotech Holdings Inc. and Filament Health Corp. Announce GMP Release of EMP Capsules	23-04-11
Filament Health Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-31
Filament Health Corp. Auditor Raises 'Going Concern' Doubt	23-03-30

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Filament Health Corp.

Equities

FLHLF

CA31685W1068

Other languages

Filters